Indur Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 5.00 Cr
as on 17-07-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.80 Cr
as on 17-07-2024
- Revenue -63.76%
(FY 2023)
- Profit 100.27%
(FY 2023)
- Ebitda 143.30%
(FY 2023)
- Net Worth 0.31%
(FY 2023)
- Total Assets 26.23%
(FY 2023)
About Indur Life Sciences
The Corporate was formerly known as Indur Pharma City Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹4.80 Cr.
Muralidhar Rambathri, Hema Rambathri, Gouthami Gankidi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U45208TG2011PTC073379
- Company No.
073379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indur Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muralidhar Rambathri  | Managing Director | 18-Mar-2011 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hema Rambathri | Director | 25-Feb-2012 | Current |
| Gouthami Gankidi | Additional Director | 17-Mar-2023 | Current |
| Raghotham Enakonda | Director | 08-Oct-2020 | Current |
| Ajay Karnavathula | Additional Director | 23-Mar-2023 | Current |
Financial Performance of Indur Life Sciences.
Indur Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.76% decrease. The company also saw a substantial improvement in profitability, with a 100.27% increase in profit. The company's net worth moved up by a moderate rise of 0.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indur Life Sciences?
In 2023, Indur Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maa Laboratories Private LimitedActive 14 years 5 monthsMuralidhar Rambathri and Hema Rambathri are mutual person
- Gvr Infraconstructions India Private LimitedActive 10 years 8 months
Gouthami Gankidi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 May 2019 | ₹4.80 Cr | Open |
How Many Employees Work at Indur Life Sciences?
Unlock and access historical data on people associated with Indur Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indur Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indur Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
